TET2 and myelodysplastic syndrome: TET2 is frequently mutated in human chronic myelomonocytic leukemia (40), and its loss promotes myelodysplastic syndrome (MDS) and myeloid and lymphoid leukemia in mice (14, 15, 41–43).